Overview of Dr. Mathew
Matthen Mathew, MD is a hematologist/oncologist at the Lynn Cancer Institute, Baptist Health South Florida. He received his medical degree from the University of Florida College of Medicine where he was elected to the Alpha Omega Alpha medical honor society. He completed internship and residency in Internal Medicine at the Icahn School of Medicine at Mount Sinai, where he served as Chief Resident. He then completed fellowship training in Hematology and Medical Oncology at New York Presbyterian Hospital/Columbia University Medical Center, where he was appointed Chief Fellow. From 2018-2020, he was an Assistant Professor of Medicine in the Division of Hematology-Oncology, Vagelos College of Physicians and Surgeons at Columbia University and member of the Herbert Irving Comprehensive Cancer Center specializing in the treatment of cancers of lung, head and neck. His research focuses on advancing new and more effective treatments for patients including novel drug combinations, targeted therapies and immunotherapies. He is board certified in Internal Medicine, Medical Oncology, and Hematology and is a member of the American Society of Clinical Oncology and the American Society of Hematology.
Office
701 NW 13th St
Fl 2
Boca Raton, FL 33486Fax+1 561-955-6618
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Hematology and Medical Oncology, 2015 - 2018
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2011 - 2014
- University of Florida College of MedicineClass of 2011
Certifications & Licensure
- FL State Medical License 2020 - 2026
- NY State Medical License 2012 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 29 citationsSingle-cell RNA sequencing reveals distinct T cell populations in immune-related adverse events of checkpoint inhibitors.Shoiab Bukhari, Brian S Henick, Robert J Winchester, Shalom Lerrer, Kieran Adam
Cell Reports. Medicine. 2023-01-17 - 96 citationsCombining chemotherapy with PD-1 blockade in NSCLC.Matthen Mathew, Thomas Enzler, Catherine A. Shu, Naiyer A. Rizvi
Pharmacology & Therapeutics. 2018-01-31 - 62 citationsExtracellular Vesicles as Biomarkers in Cancer Immunotherapy.Matthen Mathew, Mariam Zade, Nadia Mezghani, Romil Patel, Yu Wang
Cancers. 2020-09-30
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: